Glucose-lowering treatments and COVID-19 mortality in T2DM

Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19

(2021) Igor H. Murai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

(2021) Kamlesh Khunti et al.   Lancet Diabetes & Endocrinology

The Magic of Randomization versus the Myth of Real-World Evidence

(2020) Rory Collins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?

(2020) Niki Katsiki et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis

(2020) Chia Siang Kow et al.   JOURNAL OF MEDICAL VIROLOGY

Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

(2020) Bo Yu et al.   Cell Metabolism

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

(2020) Jean-Daniel Lalau et al.   DIABETES & METABOLISM

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

(2020) Stuart J McGurnaghan et al.   Lancet Diabetes & Endocrinology

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

(2019) Elisabetta Patorno et al.   DIABETES CARE

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

(2019) Julio Rosenstock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION